ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      97,741.16
      -0.37%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Silverback Therapeutics Inc (SBTX) Quote

      Silverback Therapeutics Inc

      Silverback Therapeutics Inc (SBTX)

      Skinbiotherapeutics Plc
      5.87
      0.00
      (0.00%)
      Closed January 04 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      5.87
      Bid
      2.37
      Ask
      6.15
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      563.502M
      Previous Close
      5.87
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      95,997,000
      Dividend Yield
      -
      PE Ratio
      -19.76
      Earnings Per Share (EPS)
      -0.57
      Revenue
      30k
      Net Profit
      -54.37M

      About Silverback Therapeutics Inc

      Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      ars-pharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      SBTX Latest News

      More News

      ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

      Data to be Presented in Five Poster Presentations at the 2023 American Academy of Allergy, Asthma and Immunology Annual Meeting Data Support New Drug Application for neffy®, Currently Under Review...

      February 23 2023
      GlobeNewswire Inc.

      ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

      SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

      February 22 2023
      GlobeNewswire Inc.

      ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

      SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

      February 09 2023
      GlobeNewswire Inc.

      ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

      Data from Pivotal Clinical Trials to be Presented in Five Poster Presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific Meeting Data Support New Drug...

      November 10 2022
      GlobeNewswire Inc.

      ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

      Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA Currently Under...

      November 08 2022
      GlobeNewswire Inc.

      Silverback Therapeutics' Nasal Spray for Allergic Reactions Gets FDA Review Approval

      By Sabela Ojea Silverback Therapeutics Inc. said Friday that the U.S. Food and Drug Administration has accepted for review its new drug application for Neffy, an emergency nasal spray to treat...

      October 21 2022
      Dow Jones News

      Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

      neffy has potential to be the first non-injectable medicine indicated to treat allergic reactions (type I) including anaphylaxis in the U.S., if approved Silverback Therapeutics, Inc. (Nasdaq:...

      October 21 2022
      Business Wire

      Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

      Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expected Companies to host...

      July 21 2022
      Business Wire

      Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

      Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

      May 17 2022
      Business Wire

      Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

      Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

      May 12 2022
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      SBTX - Frequently Asked Questions (FAQ)

      What is the current Silverback Therapeutics share price?
      The current share price of Silverback Therapeutics is $ 5.87
      How many Silverback Therapeutics shares are in issue?
      Silverback Therapeutics has 95,997,000 shares in issue
      What is the market cap of Silverback Therapeutics?
      The market capitalisation of Silverback Therapeutics is USD 563.5M
      What is the 1 year trading range for Silverback Therapeutics share price?
      Silverback Therapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Silverback Therapeutics?
      The price to earnings ratio of Silverback Therapeutics is -19.76
      What is the cash to sales ratio of Silverback Therapeutics?
      The cash to sales ratio of Silverback Therapeutics is 37.3k
      What is the reporting currency for Silverback Therapeutics?
      Silverback Therapeutics reports financial results in USD
      What is the latest annual turnover for Silverback Therapeutics?
      The latest annual turnover of Silverback Therapeutics is USD 30k
      What is the latest annual profit for Silverback Therapeutics?
      The latest annual profit of Silverback Therapeutics is USD -54.37M
      What is the registered address of Silverback Therapeutics?
      The registered address for Silverback Therapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
      What is the Silverback Therapeutics website address?
      The website address for Silverback Therapeutics is ars-pharma.com
      Which industry sector does Silverback Therapeutics operate in?
      Silverback Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      FCUVFocus Universal Inc
      $ 0.9499
      (174.93%)
      		260.93M
      NITON2OFF Inc
      $ 2.6306
      (145.85%)
      		358.28M
      CRNCCerence Inc
      $ 19.33
      (143.76%)
      		161.8M
      KITTNauticus Robotics Inc
      $ 3.8249
      (140.56%)
      		104.8M
      ACONAclarion Inc
      $ 0.2984
      (110.14%)
      		305.64M
      HWHHWH International Inc
      $ 0.4621
      (-28.80%)
      		7.43M
      SMSTDefiance Daily Target 2x Short MSTR ETF
      $ 5.69
      (-26.30%)
      		24.77M
      RAINRain Enhancement Technologies Holdco Inc
      $ 5.59
      (-23.42%)
      		161.15k
      PTLEPTL Ltd
      $ 9.35
      (-23.30%)
      		1.04M
      NXUNXU Inc
      $ 0.725868
      (-22.78%)
      		7.59M
      NITON2OFF Inc
      $ 2.6306
      (145.85%)
      		350.92M
      TGLTreasure Global Inc
      $ 0.382
      (101.58%)
      		330.82M
      ACONAclarion Inc
      $ 0.2984
      (110.14%)
      		305.59M
      FCUVFocus Universal Inc
      $ 0.9499
      (174.93%)
      		259.78M
      NVDANVIDIA Corporation
      $ 144.47
      (4.45%)
      		222.72M

      Discussion

      View Full Feed
      bradford86 bradford86 5 minutes ago
      People closer to the trump transition team than i am seem to be suggesting the base case is spspa writedown, which i think puts commons at $10+. The main reason i have owned preferred is the spspa conversion scenario.

      So it is looking up for you from what I am hearing. Ackman’s valua
      FNMA
      Donotunderstand Donotunderstand 5 minutes ago
      no

      preferreds get paid by a company or court in an 11

      otherwise --- the preference is ONLY on dividends

      read Investopedia or the like
      FNMA
      Toronto_Trader Toronto_Trader 5 minutes ago
      There’s no was this ticker was dead (no bid) and trading at $0.00001-0.0001 for months, rises from the ashes on a major material event and is then put on a shelf never to trade again.

      I’m not sure if some are just cautious or it’s total negative sentiment. Either way, I’m excited to
      TWOG
      Donotunderstand Donotunderstand 6 minutes ago
      You get what you pay for

      If you trade in a way were seconds -- seconds - can cost or make Thousands of dollars --- then shell out for an account and ability to trade accordingly

      I am certain you want el cheapo cost and performance that comes with buying the servi
      FNMA
      havnagoodtime havnagoodtime 7 minutes ago
      Yeah, anyway. I thought he was being facetious when I first read that post but I was giving him too much credit. Imagining the thought process >> His alias includes "Kay" so he must actually be female. SMH.
      HMBL
      al44 al44 7 minutes ago
      Walt Disney Corporation: The journey from Fantasia to transgenderism

      By Andrea Widburg

      I found myself watching Walt Disney’s Fantasia last night. As always, I was struck by the dazzlingly beautiful hand-drawn cartoons and by the Art Deco charm and kitsch, both of which
      Toronto_Trader Toronto_Trader 7 minutes ago
      I most certainly say it will trade again, and soon. Prepare to be amazed!

      $TWOH
      TWOH
      Magnum7419 Magnum7419 8 minutes ago
      Streaming Revenue Model to Launch in late December

      Our digital ads program aka Vast Tags was approved for on-ramping and launch with Whale TV https://www.whaletv.com/ yesterday December 3, 2024. Whale TV is the operating system for over 400 Smart TV brands such as Phillips, JVC and RC
      AHRO
      Donotunderstand Donotunderstand 9 minutes ago
      I wonder if you have cause and effect backwards

      listing does not make a stock go up - many listed stocks go down or 11

      the value expected from ownership - with the steps to release announced and expectations from DJT and Ackman drove the PPS up

      If such
      DJT
      glenn1919 glenn1919 10 minutes ago
      wct......................https://stockcharts.com/h-sc/ui?s=wct&p=W&b=5&g=0&id=p86431144783
      WCT
      Magnum7419 Magnum7419 10 minutes ago
      'For the period of October and November 2024, we collected $36,195 in ad revenue from our insert ad inventory sales. For the same period, Bauza Media booked $99,821.35 in ad sales, which will be reported on our balance sheet and subsequently on our income statement as we collect on the invoices from
      AHRO
      zakattack zakattack 10 minutes ago
      Why cant we get a shareholder update this month we as shareholders have no idea what is going on now
      GNCP
      BBANBOB BBANBOB 11 minutes ago
      Marty Gruenburg (sp)
      COOP
      Investor2014 Investor2014 12 minutes ago
      On another computer ChatGPT declares itself as version 4 and here I can also drag and drop a file to ask questions about.
      AVXL
      justus1 justus1 13 minutes ago
      Yes but what if ....... will always be the question until payday shows up.


      https://www.youtube.com/watch?v=PRpiBpDy7MQ
      NLST
      blackhawks blackhawks 13 minutes ago
      We need more bible thumping from sanctimonious MAGAts

      https://i.imgur.com/7HuARdH.jpeg
      81vette 81vette 14 minutes ago
      Macd about to cross to bullish,getting loaded for some reason,expecting event news soon
      GNLN
      jimr1717 jimr1717 14 minutes ago
      Newbies Updated ATMH DD>> 🏆️


      Filed a Form S-1 Registration Statement,
      are offering shares of the Company's common stock to the public.
      As soon as practicable after the effective date of this Registration Statement.

      PROSPECTUS
      All Thi
      ATMH
      blackhawks blackhawks 14 minutes ago
      We need more bible thumping from sanctimonious MAGAts

      https://i.imgur.com/7HuARdH.jpeg
      Donotunderstand Donotunderstand 14 minutes ago
      huh?

      what would that look like ?

      how would capital requirements be met

      how would the deficit be worked on

      what would that look like?
      FNMA
      blackhawks blackhawks 14 minutes ago
      He 'must disagree with her interpretation of events'. How else to accurately portray the amoral generosity of those depicted in the cartoon? What purpose for the money other than to inoculate the 'givers' from receiving the displeasure of the Orange Mussolini?
      glenn1919 glenn1919 15 minutes ago
      vvpr............................https://stockcharts.com/h-sc/ui?s=Vvpr&p=W&b=5&g=0&id=p86431144783
      VVPR
      Chartmaster Chartmaster 16 minutes ago
      Yeah sure, and don't forget to read the prospectus right? LMAO!!!😃
      RDAR

      Your Recent History

      NASDAQ
      SBTX
      Silverback Therapeutics
      NYSE
      BP
      BP
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads